(Total Views: 425)
Posted On: 09/18/2020 3:40:48 PM
Post# of 74

$SGEN News Article - Astellas and Seattle Genetics Announce PADCEV (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer https://marketwirenews.com/news-releases/aste...24363.html
My Twitter: WhyteStocks